Skye Global Management LP Renalytix PLC Transaction History

Skye Global Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $42,140 - $134,332	-17,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.88 - $15.9 $62,328 - $168,540	10,600 Added 160.61%	17,200 $119,000
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $88,638 - $180,840	6,600 New	6,600 $105,000
Q3 2021 Nov 15, 2021	SELL	$17.91 - $34.78 $698,490 - $1.36 Million	-39,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.56 - $34.25 $400,520 - $582,250	17,000 Added 77.27%	39,000 $1.2 Million
Q1 2021 May 14, 2021	BUY	$15.25 - $31.13 $335,500 - $684,860	22,000 New	22,000 $565,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Skye Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Skye Global Management LP with notifications on news.